| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Animal disease models for drug screening: the elephant in the room?
|
Tsukamoto, Takashi
|
|
2016
|
21 |
4 |
p. 529-530
2 p.
|
article
|
| 2 |
Applying lessons learned from cytomegalovirus infection in transplant patients to vaccine design
|
Blanco-Lobo, Pilar
|
|
2016
|
21 |
4 |
p. 674-681
8 p.
|
article
|
| 3 |
Characterisation and surface-profiling techniques for composite particles produced by dry powder coating in pharmaceutical drug delivery
|
Dahmash, Eman Z.
|
|
2016
|
21 |
4 |
p. 550-561
12 p.
|
article
|
| 4 |
Characteristics of product recalls of biopharmaceuticals and small-molecule drugs in the USA
|
Ebbers, Hans C.
|
|
2016
|
21 |
4 |
p. 536-539
4 p.
|
article
|
| 5 |
Compound high-quality criteria: a new vision to guide the development of drugs, current situation
|
Mignani, Serge
|
|
2016
|
21 |
4 |
p. 573-584
12 p.
|
article
|
| 6 |
Contents page 1
|
|
|
2016
|
21 |
4 |
p. i-
1 p.
|
article
|
| 7 |
Contents page 2
|
|
|
2016
|
21 |
4 |
p. ii-iii
nvt p.
|
article
|
| 8 |
COX-2 inhibitors: a novel strategy in the management of breast cancer
|
Regulski, Miłosz
|
|
2016
|
21 |
4 |
p. 598-615
18 p.
|
article
|
| 9 |
Crossroad between linear and nonlinear transcription concepts in the discovery of next-generation sequencing systems-based anticancer therapies
|
Roukos, Dimitrios H.
|
|
2016
|
21 |
4 |
p. 663-673
11 p.
|
article
|
| 10 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans
|
Chen, Minjun
|
|
2016
|
21 |
4 |
p. 648-653
6 p.
|
article
|
| 11 |
Drugging specific conformational states of GPCRs: challenges and opportunities for computational chemistry
|
Martí-Solano, Maria
|
|
2016
|
21 |
4 |
p. 625-631
7 p.
|
article
|
| 12 |
Drug leads for interactive protein targets with unknown structure
|
Fernández, Ariel
|
|
2016
|
21 |
4 |
p. 531-535
5 p.
|
article
|
| 13 |
Human microbial metabolites as a source of new drugs
|
Saha, Somdutta
|
|
2016
|
21 |
4 |
p. 692-698
7 p.
|
article
|
| 14 |
Interactions between carbon nanotubes and bioactives: a drug delivery perspective
|
Mehra, Neelesh Kumar
|
|
2016
|
21 |
4 |
p. 585-597
13 p.
|
article
|
| 15 |
Locoregional cancer therapy using polymer-based drug depots
|
Ramazani, Farshad
|
|
2016
|
21 |
4 |
p. 640-647
8 p.
|
article
|
| 16 |
Matched analysis on orphan drug designations and approvals: cross regional analysis in the United States, the European Union, and Japan
|
Murakami, Manabu
|
|
2016
|
21 |
4 |
p. 544-549
6 p.
|
article
|
| 17 |
Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis
|
Karuppagounder, Vengadeshprabhu
|
|
2016
|
21 |
4 |
p. 632-639
8 p.
|
article
|
| 18 |
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes
|
Clementi, Nicola
|
|
2016
|
21 |
4 |
p. 682-691
10 p.
|
article
|
| 19 |
p53 family interactions and yeast: together in anticancer therapy
|
Gomes, Sara
|
|
2016
|
21 |
4 |
p. 616-624
9 p.
|
article
|
| 20 |
Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein
|
Chang, Chung-ke
|
|
2016
|
21 |
4 |
p. 562-572
11 p.
|
article
|
| 21 |
The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers
|
Salehifar, Ebrahim
|
|
2016
|
21 |
4 |
p. 654-662
9 p.
|
article
|
| 22 |
Ultrasound-targeted microbubble destruction: toward a new strategy for diabetes treatment
|
Mozafari, Masoud
|
|
2016
|
21 |
4 |
p. 540-543
4 p.
|
article
|
Journal description